More data coming
Looking ahead, “we only showed efficacy in the first 2 days of treatment and a shorter length of stay, probably reflecting a faster decongestion, but we don’t know for sure,” Dr. Dauw told this news organization.
“It would be important to have a study where the protocol is followed until full decongestion is reached,” he said. “That way, we can directly prove that decongestion is better and/or faster with the protocol.”
“A good decongestive strategy is one that is fast, safe and effective in decreasing signs and symptoms that patients suffer from,” he added. “We believe our protocol can achieve that, but our study is only one piece of the puzzle.”
More data on natriuresis-guided decongestion is coming this year, he said, with the PUSH-AHF study from Groningen, the European DECONGEST study, and the U.S. ESCALATE study.
The study had no funding. Dr. Dauw declared no relevant financial relationships.
A version of this article originally appeared on Medscape.com.